As the medication builds up in your system, its ability to suppress appetite becomes more pronounced, and patients often report feeling more satisfied with smaller portions and fewer cravings for unhealthy foods
Some patients may have nausea, vomiting, diarrhea, constipation, stomach discomfort, appetite changes, or dehydration risk
Is MOTS-c safe to use for results
GLP-1 Consumer Survey
Microdosing approaches , where the dose is increased in smaller increments than standard protocols, are another option gaining attention
Practical Considerations in Research: Experimental investigations often prioritize injectables for systemic effects, whereas oral delivery is examined when local gastrointestinal action or non-invasive delivery is desired